IRIS
DICHIARA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.407
EU - Europa 2.023
AS - Asia 1.319
AF - Africa 251
SA - Sud America 184
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.341
IT - Italia 732
SG - Singapore 657
RU - Federazione Russa 561
CN - Cina 346
DE - Germania 222
BR - Brasile 160
CI - Costa d'Avorio 155
IE - Irlanda 134
FI - Finlandia 109
VN - Vietnam 108
FR - Francia 69
KR - Corea 62
GB - Regno Unito 52
CA - Canada 45
ES - Italia 35
SN - Senegal 33
IN - India 24
NG - Nigeria 24
UA - Ucraina 24
JP - Giappone 22
BD - Bangladesh 21
HK - Hong Kong 18
SE - Svezia 14
ID - Indonesia 13
PL - Polonia 13
IQ - Iraq 12
NL - Olanda 12
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
AR - Argentina 8
BE - Belgio 7
KE - Kenya 7
MX - Messico 7
TR - Turchia 7
BJ - Benin 6
CL - Cile 6
GR - Grecia 6
AU - Australia 5
JM - Giamaica 5
MA - Marocco 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
EC - Ecuador 4
HU - Ungheria 4
AL - Albania 3
CH - Svizzera 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
LT - Lituania 3
NZ - Nuova Zelanda 3
CO - Colombia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AO - Angola 1
BZ - Belize 1
DK - Danimarca 1
GA - Gabon 1
HR - Croazia 1
KG - Kirghizistan 1
ME - Montenegro 1
MM - Myanmar 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.193
Salva come PNG Salva come JPEG
Città #
Singapore 420
Dallas 372
Chandler 295
Santa Clara 284
Moscow 281
San Jose 191
Munich 187
Catania 174
Ashburn 157
Abidjan 155
Chicago 142
Dublin 133
Hefei 81
Helsinki 81
Beijing 65
Seoul 61
Civitanova Marche 60
Boardman 54
Los Angeles 53
Lauterbourg 42
Naples 38
Ho Chi Minh City 35
Lawrence 34
Cambridge 33
Dakar 33
Andover 31
New York 30
Nanjing 28
Council Bluffs 27
Hanoi 26
Bremen 21
Des Moines 21
Milan 20
Rome 20
Tokyo 20
Toronto 20
Buffalo 19
Houston 19
Palermo 19
Hong Kong 18
São Paulo 18
Denver 17
Jacksonville 17
Montreal 16
Phoenix 14
The Dalles 14
Brooklyn 13
Lagos 13
Orem 13
Columbus 12
Jyväskylä 12
Madrid 12
Messina 11
Poplar 11
Centro 10
London 10
Warsaw 10
Florence 9
Jakarta 9
Johannesburg 9
Abuja 8
Brno 8
Lappeenranta 8
Sala Baganza 8
Atlanta 7
Cagliari 7
Hebei 7
Mascalucia 7
Pozzallo 7
San Francisco 7
Shenyang 7
Stockholm 7
Wilmington 7
Bari 6
Belo Horizonte 6
Changsha 6
Cotonou 6
Da Nang 6
Marseille 6
Nanchang 6
Saint Petersburg 6
Scafati 6
Terrassa 6
Amsterdam 5
Basingstoke 5
Brussels 5
Chennai 5
Civitavecchia 5
Dong Ket 5
Groningen 5
Guangzhou 5
Paris 5
Raffadali 5
Santiago 5
Aci Catena 4
Bologna 4
City of London 4
Curitiba 4
Haiphong 4
Jiaxing 4
Totale 4.284
Salva come PNG Salva come JPEG
Nome #
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 297
Composti inorganici [Cap. 6] 274
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer 199
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 186
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 176
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties 165
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 157
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 157
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 155
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 153
Development of Sigma Receptors Nitric Oxide Photodonor Ligands with Antiproliferative Activity 150
Design and Synthesis of Tetrahydropyrrolo[3,4‐c]Pyrazole Sigma‐1 Receptor Ligands 149
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 149
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 144
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 141
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 140
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 136
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 136
CNS permeability parameters determination through a statistical analysis driven approach 132
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 131
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 131
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 128
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 128
Development of NO-releasing sigma receptor hybrids as anticancer agents 128
Development of novel H2S-donor sigma receptor hybrids for the management of pain. 127
Tumor Targeting Sigma Receptor Ligands: Development of New Molecular Hybrids as Anticancer Therapeutics 126
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 124
Sigma-2 receptor ligands QSAR model dataset 124
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 123
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 120
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 118
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 117
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 116
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 116
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 116
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 113
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 110
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 104
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands 96
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 95
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 87
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 86
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 83
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 79
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 74
Repurposing of human kinase inhibitors in neglected protozoan diseases 74
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties 74
Sintesi e valutazione preclinica di ligandi per i recettori sigma utili per il trattamento dei tumori e per la gestione del dolore 72
H2S releasing molecules in pharmaceutical development 69
Totale 6.385
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022320 19 39 26 15 47 4 42 8 23 16 4 77
2022/2023745 69 66 15 107 49 116 8 123 143 9 34 6
2023/2024435 21 58 17 19 37 133 21 19 1 8 70 31
2024/20251.602 55 214 56 125 221 200 201 105 163 82 92 88
2025/20262.825 181 145 442 215 399 650 263 56 180 166 94 34
Totale 6.385